By systematically comparing the sexual side effects and prolactin-related impacts of various antipsychotics, this study aims to provide clinicians with evidence-based guidance for selecting medications that minimize sexual dysfunction, a key factor affecting patient adherence. This evidence concerns the gene PRL and sexual dysfunction.